Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab

Saved in:
Bibliographic Details
Published in:Clinical and experimental allergy 2021-12, Vol.51 (12), p.1648-1652
Main Authors: Al‐Shaikhly, Taha, MacDonald, James W., Bammler, Theo K., Altman, Matthew C., Ayars, Andrew G., Petroni, Daniel H., Tilles, Stephen A., Henderson, William R.
Format: Article
Language:English
Subjects:
Anti-Allergic Agents - therapeutic use
Basophils
Chronic Disease
chronic spontaneous urticarial
Chronic Urticaria - drug therapy
Humans
Immunoglobulin E
microRNA
MicroRNAs
miRNA
Monoclonal antibodies
omalizumab
Omalizumab - therapeutic use
response biomarker
Urticaria
Urticaria - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0954-7894
1365-2222
DOI:10.1111/cea.14014